Jul 27, 2024, 08:53
ASCO’s rapid guideline update on the management of stage III NSCLC
American Society of Clinical Oncology (ASCO) shared a post on X:
“For more on our recent rapid guideline update on the management of stage III NSCLC, based on the results of the phase 3 LAURA trial, ASCO Daily News has a detailed analysis and an interview with Expert Panel co-chair Navneet Singh.
Source: ASCO/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59